Ірландія - англійська - HPRA (Health Products Regulatory Authority)

pfizer limited - ziprasidone hydrochloride monohydrate - capsules hard - 60 milligram

Ірландія - англійська - HPRA (Health Products Regulatory Authority)

pfizer healthcare ireland - fluconazole - capsules hard - 150 milligram

Австралія - англійська - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - mefenamic acid, quantity: 250 mg - capsule, hard - excipient ingredients: gelatin; carbon black; iron oxide yellow; brilliant blue fcf; lactose monohydrate; titanium dioxide - treatment of primary dysmenorrhoea and primary menorrhoea. short-term relief of mild to moderate pain such as dental pain and soft tissue pain.

Австралія - англійська - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - isavuconazonium sulfate, quantity: 186.3 mg (equivalent: isavuconazole, qty 100 mg) - capsule - excipient ingredients: potassium acetate; gellan gum; iron oxide red; sodium lauryl sulfate; titanium dioxide; hypromellose; disodium edetate; magnesium citrate; microcrystalline cellulose; purified talc; colloidal anhydrous silica; stearic acid; propylene glycol; butan-1-ol; purified water; isopropyl alcohol; shellac; strong ammonia solution; ethanol absolute; iron oxide black; potassium hydroxide - cresemba is indicated in adults for the treatment of ? invasive aspergillosis ? mucormycosis in patients for whom amphotericin b is inappropriate (see section 4.4 special warnings and precautions for use and section 5.1 pharmacodynamic properties),consideration should be given to official guidance on the appropriate use of antifungal agents.

Сінгапур - англійська - HSA (Health Sciences Authority)

pfizer private limited - fluconazole - capsule - 50 mg - fluconazole 50 mg

Нова Зеландія - англійська - Medsafe (Medicines Safety Authority)

pfizer new zealand limited - sunitinib malate 16.7mg equivalent to sunitinib 12.5mg;   - capsule - 12.5 mg - active: sunitinib malate 16.7mg equivalent to sunitinib 12.5mg   excipient: croscarmellose sodium gelatin ink iron oxide red magnesium stearate mannitol povidone sodium laurilsulfate titanium dioxide - treatment of advanced renal cell carcinoma

Нова Зеландія - англійська - Medsafe (Medicines Safety Authority)

pfizer new zealand limited - sunitinib malate 33.4mg equivalent to sunitinib 25mg;   - capsule - 25 mg - active: sunitinib malate 33.4mg equivalent to sunitinib 25mg   excipient: croscarmellose sodium gelatin ink iron oxide black iron oxide red iron oxide yellow magnesium stearate mannitol povidone sodium laurilsulfate titanium dioxide - treatment of advanced renal cell carcinoma

Нова Зеландія - англійська - Medsafe (Medicines Safety Authority)

pfizer new zealand limited - sunitinib malate 50.1mg equivalent to sunitinib 37.5mg;   - capsule - 37.5 mg - active: sunitinib malate 50.1mg equivalent to sunitinib 37.5mg   excipient: croscarmellose sodium gelatin ink iron oxide yellow magnesium stearate mannitol povidone sodium laurilsulfate titanium dioxide - treatment of advanced renal cell carcinoma

Нова Зеландія - англійська - Medsafe (Medicines Safety Authority)

pfizer new zealand limited - sunitinib malate 66.8mg equivalent to sunitinib 50mg;   - capsule - 50 mg - active: sunitinib malate 66.8mg equivalent to sunitinib 50mg   excipient: croscarmellose sodium gelatin ink iron oxide black iron oxide red iron oxide yellow magnesium stearate mannitol povidone sodium laurilsulfate titanium dioxide - treatment of advanced renal cell carcinoma

Велика Британія - англійська - myHealthbox

pfizer limited - amlodipine besilate - hard capsule - 5mg - calcium channel blockers, selective calcium channel blockers with mainly vascular effects - hypertension chronic stable angina pectoris vasospastic (prinzmetal’s) angina